Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
Date:11/8/2010

accelerated the rate of viral clearance, with comparable response at ANA598 doses of 200 mg bid and 400 mg bid.  ANA598 also showed an excellent safety profile in the study through the 12 weeks of dosing, with reported adverse events being typical for patients treated with interferon and ribavirin alone, although conclusions regarding safety cannot be made until results in more patients over longer duration are known.  Slides from the oral presentation are available on the Company's website at www.anadyspharma.com.On November 2, 2010, additional data from the ongoing Phase IIa trial were presented at AASLD showing that the addition of ANA598 to SOC conferred benefit in both the patients with the IL-28B genotypes most and less responsive to SOC in a poster titled, "IL28B Polymorphism and Kinetics of Antiviral Activity for ANA598 in Combination with Pegylated Interferon alpha 2A Plus Ribavirin in Treatment-Naïve Genotype-1 Chronic HCV Patients."  The poster is available on the Company's website at www.anadyspharma.com.


  • Phase IIa Study of ANA773 in HCV.  In October, Anadys announced that it plans to resume clinical investigation of ANA773 in hepatitis C patients.  ANA773 is an oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway.  The Company intends to conduct a 28-day study of ANA773, in combination with ribavirin in the first cohorts and as triple therapy in combination with ribavirin and a direct-acting antiviral (DAA) in subsequent cohorts. Anadys intends to conduct this study in Europe and potentially other countries, and expects that up to approximately 75 patients will participate in the trial, inclusive of the DAA cohorts.Recent Operational Highlights

  • Closed Underwritten Public Offering of Common Stock.  In October, Anadys closed an underwritten public offering through the sale of c
    '/>"/>


  • SOURCE Anadys Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
    2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
    3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
    4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
    5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
    6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
    7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
    8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
    9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
    10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
    11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... BEIJING , Sept. 2, 2014  Sinovac Biotech Ltd. ... products in China , today announced that ... in September: , Morgan Stanley Global Healthcare Conference, ... September 9 and 10, 2014. , Morgan Stanley Asia ... Hotel on September 11, 2014. , Aegis Healthcare & ...
    (Date:9/2/2014)... delivery technologies that improve access and overall efficacy ... drug development process. Pharmaceutical companies are particularly investing ... in a bid to move away from needles ... New analysis from Frost & Sullivan, Needle-Free Nanopatch ... currently makes up a small fraction of the ...
    (Date:9/2/2014)... Calif. , Sept. 2, 2014 /PRNewswire-iReach/ -- ... just recognized as one of the fastest growing ... past few years, the company has undergone significant ... research, late phase global clinical development, anti-viral and ... 2 years, WCCT Global has successfully participated in ...
    Breaking Medicine Technology:Sinovac to Participate in Upcoming Investor Conferences 2Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan 2Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan 3Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America 2
    ... 22, 2011 Innovative Dialysis Systems, Inc. announces the ... in and around Los Angeles with more options for ... are located in Northridge, Torrance, Carson, and downtown Los ... Reseda Boulevard, was the first of the new centers ...
    ... 22, 2011     ... catch up   with   their urban counterparts in adopting technology ...   data spill shows risk of online health records . ... IT and its current challenges? Ambitious national healthcare IT programmes and ...
    Cached Medicine Technology:Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California 2Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California 3Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2
    (Date:9/2/2014)... Request A Test , a leading national provider of direct ... drug testing in September 2014. To take advantage ... DRUG10 when placing their order. Request A Test offers a ... testing is typically done in panels which screen for multiple types ... include the 5 Panel Urine Screening and 10 ...
    (Date:9/2/2014)... support for marijuana legalization in the U.S. has led ... other substances, such as alcohol. In January, President Obama ... is more dangerous than alcohol. Despite the recent shift ... compared to alcohol use are not well understood. ... Associated with Drug Use among US High School Seniors: ...
    (Date:9/2/2014)... Tuesday 2 September 2014: A simple awareness campaign in ... according to research presented at ESC Congress today by ... "Atrial fibrillation (AF) is the most common cardiac arrhythmia. ... three-fold and the risk of stroke risk by five-fold. ... of 4 cases. However, AF is often overlooked and ...
    (Date:9/2/2014)... September 02, 2014 Aeroflow Healthcare, an ... the Southeast, announced the opening of its new office ... address is: 310 Business Parkway, Suite D, Greer, SC ... service patients with a more convenient location in the ... Aeroflow Healthcare and the physicians, hospitals and patients we ...
    (Date:9/2/2014)... September 2014 – The days when skin care ... men shave daily – and commit common mistakes that can ... isn’t inevitable, according to Joshua Fox, MD, medical ... skin care was something in which only women seemed interested. ... all ages who realize that their fathers’ bare-bones routine of ...
    Breaking Medicine News(10 mins):Health News:Request A Test Offers 10% Off Drug Testing in September 2014 2Health News:Request A Test Offers 10% Off Drug Testing in September 2014 3Health News:NYU study compares consequences of teen alcohol and marijuana use 2Health News:NYU study compares consequences of teen alcohol and marijuana use 3Health News:Simple awareness campaign in general practice identifies new cases of AF 2Health News:Aeroflow Healthcare Opens Office In Greer, SC To Service Greenville & Spartanburg Patients 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 3
    ... children are not checked properly for their safety ... University Medical Center researchers. // The drugs that ... and sedatives. ,The researchers analyzed drugs ... "pediatric exclusivity," through which the Food and Drug ...
    ... growing number of HIV infected individuals, India plans to ask ... the country to // teach others about safe sex and ... weavers, or agricultural laborers or just be hanging around the ... National Aids Control Organization "But the point is the distribution ...
    ... being reported from Rajasthan, officials say. According to the health ... with symptoms of dengue. Last month the number was 15. ... have been reported from Dholpur, Karauli and Sawai Madhopur districts. ... state, the government has stepped up measures to control the ...
    ... factors that are linked with an increased risk for ... long-QT syndrome (an abnormality of the electrical conducting system ... the ECG), according to a study. ,Risk factors ... an episode of cardiac arrest is reversed, such as ...
    ... new study commissioned by the World Health Organization has suggested ... treatments may work against SARS// in the event of the ... that was conducted during and after the 2003 outbreak that ... of any treatments employed that had any effect on the ...
    ... obstructive pulmonary disease (COPD) who use inhaled corticosteroids ... according to a new study published in the ... the American College of Chest Physicians (ACCP). New ... within 30 days of hospital discharge had a ...
    Cached Medicine News:Health News:Doctors Unaware If Pediatric Dosages Are Safe 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 3Health News:Factors Associated With Increased Risk of Cardiac Arrest For Adolescents 2Health News:Treatment of SARS Still a Mystery 2Health News:Inhaled Corticosteroids Reduce Death in Patients with COPD 2
    ... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
    ... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
    ... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
    ... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
    Medicine Products: